Uses of fibroblasts or supernatants from fibroblasts for the suppression of immune responses in transplantation
View Patent ↗Disclosed is a method of inducing a reduced immune response to a transplant in a recipient by treating said recipient with an amount of fibroblasts or a supernatant from a fibroblast culture effective to reduce or inhibit host rejection of the transplant. The fibroblasts or a supernatant from a fibroblast culture can be administered before, at the same time as, or after the transplant. This method is effective in reducing an immune response to a transplant without compromising the immune response to other foreign antigens. Also disclosed is a method of inducing a reduced immune response against a host by foreign tissue, i.e., graft versus host disease.
1. A method of reducing an immune response against recipient tissue by donor tissue, comprising contacting the donor tissue with isolated fibroblasts in an amount effective to reduce an immune response by the donor tissue against the recipient;
wherein the fibroblasts are allogeneic both to the donor and to the recipient of the donor tissue.
2. A method of reducing an immune response against recipient tissue by donor tissue, comprising contacting the donor tissue with isolated fibroblasts in an amount effective to reduce an immune response by the donor tissue against the recipient;
wherein the donor tissue and the fibroblasts are contacted ex vivo prior to transplantation of the donor tissue; and
wherein the donor tissue is exposed to recipient tissue prior to being contacted with the fibroblasts.